ArticleOncoimmunology
Prophylactic use of low-dose interleukin-2 and the clinical outcomes of hematopoietic stem cell transplantation: A randomized study.
Xiang-Yu Zhao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
17 papers cite it
trialcites it